text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2022년 03월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n가산(비상장)\n비상장\n2007.07.27\n경영참여\n\xa0 \xa0100\n230,000\n100.0\n2,300\n-\n-\n-\n230,000\n100.0\n2,300\n7,716\n293\n연변광동제약(비상장)\n비상장\n2009.09.30\n""\n1,600\n-\n50.0\n4,992\n-\n-\n-\n-\n50.0\n4,992\n18,911\n552\n코리아이플랫폼(비상장)\n비상장\n2015.03.17\n""\n40,738\n4,735,861\n64.6\n42,981\n-\n-\n-\n4,735,861\n64.6\n42,981\n171,569\n3,377\nKD인베스트먼트(비상장)\n비상장\n2019.05.07\n""\n20,000\n4,000,000\n100.0\n20,000\n-\n-\n-\n4,000,000\n100.0\n20,000\n22,789\n-434\nKwangdong Vina Co.,Ltd(비상장)\n비상장\n2019.05.31\n""\n1,476\n-\n99.9\n1,476\n-\n-\n-\n-\n99.9\n1,476\n1,145\n19\n케이디바이오투자조합1호(비상장)\n비상장\n2019.09.24\n""\n2,500\n145\n83.3\n14,500\n-\n-\n-\n145\n83.3\n14,500\n22,420\n-14,038\n케이디바이오투자조합2호(비상장)\n비상장\n2020.05.07\n""\n9,000\n90\n83.3\n9,000\n-\n-\n-\n90\n83.3\n9,000\n10,343\n277\n케이디바이오투자조합3호(비상장)\n비상장\n2020.09.15\n""\n550\n55\n50.0\n550\n-\n-\n-\n55\n50.0\n550\n1,055\n35\n케이디재산투자조합2호(비상장)\n비상장\n2020.09.15\n투자목적\n800\n80\n38.1\n800\n-\n-\n-\n80\n38.1\n800\n2,031\n-35\n케이디바이오투자조합5호(비상장)\n비상장\n2021.05.20\n""\n1,500\n1,500\n53.6\n1,500\n-\n-\n-\n1,500\n53.6\n1,500\n2,756\n-43\n씨엘팜(비상장)\n비상장\n2011.05.06\n""\n2,000\n84,000\n11.0\n-\n-\n-\n-\n84,000\n11.0\n-\n31,605\n1,211\n비트로시스(비상장)\n비상장\n2017.07.31\n""\n1,005\n670,000\n9.4\n1,005\n-\n-\n-\n670,000\n9.4\n1,005\n7,787\n-49\n가이아바이오투자조합(비상장)\n비상장\n2018.09.03\n""\n2,000\n-\n32.8\n2,000\n-\n-\n-\n-\n32.8\n2,000\n5,807\n-127\n(주)바이넥스(상장)\n상장\n2020.06.26\n""\n5,279\n390,000\n1.23\n5,279\n-\n-\n-\n390,000\n1.23\n5,279\n272,488\n19,030\nOxford CancerBiomarkers Limited(비상장)\n비상장\n2019.05.20\n""\n3,036\n1,431\n11.5\n3,103\n-\n-\n-\n1,431\n11.5\n3,103\n2,682\n-1635\n합 계\n-\n-\n109,486\n-\n-\n-\n-\n-\n109,486\n-\n-\n']"
